about
Evolving concepts in cancer therapy through targeting sphingolipid metabolismPotential for layered double hydroxides-based, innovative drug delivery systemsEtoposide as a virocidal anticytomegalovirus therapy: intravitreal toxicology and pharmacology in rabbits.Insulin-like growth factor-I decreased etoposide-induced apoptosis in glioma cells by increasing bcl-2 expression and decreasing CPP32 activity.Recurrent cerebellar gliomas: salvage therapy with oral etoposide.HPLC-UV method for quantifying etoposide in plasma and tumor interstitial fluid by microdialysis: application to pharmacokinetic studies.Curcumin enhances the cytogenotoxic effect of etoposide in leukemia cells through induction of reactive oxygen speciesOral treatment with etoposide in small cell lung cancer - dilemmas and solutions.Schedule-dependent response of neuroblastoma cell lines to combinations of etoposide and cisplatin.Pharmacokinetics of chemotherapy in the older patient.Etoposide induced cytotoxicity mediated by ROS and ERK in human kidney proximal tubule cells.Synthesis and Anticancer Activities of Novel Guanylhydrazone and Aminoguanidine Tetrahydropyran Derivatives.The effect of molecular structure on the anticancer drug release rate from prodrug nanoparticles.Inhibition of CYP3A4 and CYP2C9 by podophyllotoxin: implication for clinical drug-drug interactions.Effect of additives on stability of etoposide in PLGA microspheres.Comparative study of some biodegradable polymers on the entrapment efficiency and release behavior of etoposide from microspheres.
P2860
Q26863646-AAB26D63-C1C0-45C8-B718-87EF75F2C58EQ30391504-CE68A233-07C5-41F9-A607-32D29CBB47DCQ30817132-9FDE7F71-C54B-4947-BDB2-A4FB5009A1DEQ33214021-236A5A65-FD37-40DC-852D-B9AEA2BACF70Q33499143-114B46C4-8710-4AD5-BA87-C92F10D92E3EQ35228066-E2522DDD-588F-4F19-B22B-8C967A1C34D3Q36557734-F534635A-7872-471C-90A6-74B669AC4807Q36613874-2425948C-9114-4BC7-BB94-84FF8CCA863FQ36643776-924B62EC-A41A-4110-89E7-0867C145097AQ36715263-46A87A40-C6DE-4746-83A9-7B09BBCA1AA7Q37282137-A39A8F81-08B3-49F3-A71F-B8236C28930BQ38762621-3DBB1F94-41D8-4E18-AE3A-9B05AFBCA8B8Q38854217-1B28577A-D144-4AEB-B03B-331841E5EFF3Q43519814-BC4F5B3B-2ECE-421B-8B9C-38324F6D20ECQ43644527-B7C49370-9691-4101-A5F4-CD90839AF57AQ51010715-4A1A2238-CA64-41AD-B986-12C5C0E65345
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The clinical pharmacology of etoposide.
@en
The clinical pharmacology of etoposide.
@nl
type
label
The clinical pharmacology of etoposide.
@en
The clinical pharmacology of etoposide.
@nl
prefLabel
The clinical pharmacology of etoposide.
@en
The clinical pharmacology of etoposide.
@nl
P2860
P1433
P1476
The clinical pharmacology of etoposide.
@en
P2093
P2860
P304
P356
10.1002/1097-0142(19910101)67:1+<319::AID-CNCR2820671319>3.0.CO;2-D
P407
P433
P577
1991-01-01T00:00:00Z